TD Cowen analyst Michael Nedelcovych maintained a Buy rating on Novo Nordisk (NVO – Research Report) today. The company’s shares closed ...

Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK875.00.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Nordic firms have outperformed those from the rest of Europe over the past decade. In all four countries, listed ...

Wegovy costs $1,349 here but $186 in Denmark and $92 in the U.K. Bernie Sanders launched an investigation into Novo Nordisk last year ... are lowered because PBMs profit from the rebates.

Health care, ride sharing, and the emerging world of YouTube entertainers are among industries leading investors have picked ...